Electrochemically controlled fiber‐in‐tube solid‐phase microextraction method for the determination of trace amounts of antipsychotic drugs in biological samples

In this study, a novel ‘fiber‐in‐tube’ configuration was applied to electrochemically controlled fiber‐in‐tube solid‐phase microextraction of antipsychotic drugs (perphenazine and chlorpromazine) from biological samples. To prepare an electrochemically controlled fiber‐in‐tube solid‐phase microextra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of separation science 2018-09, Vol.41 (18), p.3598-3606
Hauptverfasser: Shamsayei, Maryam, Yamini, Yadollah, Asiabi, Hamid
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this study, a novel ‘fiber‐in‐tube’ configuration was applied to electrochemically controlled fiber‐in‐tube solid‐phase microextraction of antipsychotic drugs (perphenazine and chlorpromazine) from biological samples. To prepare an electrochemically controlled fiber‐in‐tube solid‐phase microextraction column, first eight stainless‐steel wires were placed into the stainless‐steel column. Then, a nanostructured Cu‐Cr‐Al ternary layered double hydroxide/polythiophene coating was prepared on the inner surface of the stainless‐steel tube and on the surfaces of the stainless‐steel wires by a facile in situ electrodeposition method. The nanostructured coating exhibited enhanced long lifetime, good mechanical stability, high porosity, and large specific surface area compared with polythiophene and Cu‐Cr‐Al layered double hydroxide coatings. Under the optimal conditions, the limits of detection were in the range of 0.07–0.8 μg/L. This method showed good linearity for perphenazine and chlorpromazine in the ranges of 0.3–300 and 0.2–300 μg/L, respectively, with coefficients of determination more than 0.9982. The inter‐ and intra‐assay precisions (RSD%, n = 3) were in the ranges of 3.0–5.1 and 2.5–4.5% at three concentration levels of 5, 25 and 50 μg/L, respectively. Finally, the method was applied for the analysis of the drugs in human urine and plasma samples.
ISSN:1615-9306
1615-9314
DOI:10.1002/jssc.201800417